Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies. (Q54523125)

30 May 2018

title

Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies. (English)

1 reference

30 May 2018

1 reference

2

Gerhard Moldenhauer

1 reference

30 May 2018

author name string

Sergey M Kipriyanov

1

1 reference

30 May 2018

Michael Braunagel

3

1 reference

30 May 2018

Uwe Reusch

4

1 reference

30 May 2018

Björn Cochlovius

5

1 reference

30 May 2018

Fabrice Le Gall

6

1 reference

30 May 2018

Olga A Kouprianova

7

1 reference

30 May 2018

Claus Wilhelm Von der Lieth

8

1 reference

30 May 2018

Melvyn Little

9

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 June 2003

1 reference

30 May 2018

Journal of Molecular Biology

published in

1 reference

30 May 2018

volume

330

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

99-111

1 reference

30 May 2018

Immunotherapeutic perspective for bispecific antibodies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Bispecific antibodies in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

The first constant domain (CH1 and CL) of an antibody used as heterodimerization domain for bispecific miniantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

"Diabodies": small bivalent and bispecific antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Crystal structure of a diabody, a bivalent antibody fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

High level secretion of a humanized bispecific diabody from Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Treatment of human B cell lymphoma xenografts with a CD3 x CD19 diabody and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Intracellular and cell surface displayed single-chain diabodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Optimized linker sequences for the expression of monomeric and dimeric bispecific single-chain diabodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

A surface expression vector for antibody screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Crystallographic structure of an intact IgG1 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

The JAM test. A simple assay for DNA fragmentation and cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

A dimeric bispecific miniantibody combines two specificities with avidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

A simple model for proteins with interacting domains. Applications to scanning calorimetry data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Biophysical properties of human antibody variable domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Yet Another Numbering Scheme for Immunoglobulin Variable Domains: An Automatic Modeling and Analysis Tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Selection for a periplasmic factor improving phage display and functional periplasmic expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Stability engineering of antibody single-chain Fv fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: Production of bivalent and biotinylated miniantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Protein modelling for all

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Knowledge-based potentials for proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Energy functions for peptides and proteins. I. Derivation of a consistent force field including the hydrogen bond from amide crystals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Computer simulation of the solvent structure around biological macromolecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

Carboxy-terminal regions on the surface of tubulin and microtubules. Epitope locations of YOL1/34, DM1A and DM1B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900526-6

10.1016/S0022-2836(03)00526-6

7 January 2021

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018